Crossmark

GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer

Published Online: 2024-09-06

Authors

Sandström, Josefine

Bomanson, Jens

Pérez-Tenorio, Gizeh

Jönsson, Carolin

Nordenskjöld, Bo

Fornander, Tommy

Lindström, Linda S. https://orcid.org/0000-0002-7722-7532
Stål, Olle https://orcid.org/0000-0002-8290-0592
License Information

Text and Data Mining valid from 2024-09-06

Version of Record valid from 2024-09-06
More Information

Article History

Received: 17 April 2024

Accepted: 29 August 2024

First Online: 6 September 2024

Competing interests

: The authors declare no competing interests.

Document is current